Powered by its artificial intelligence software platform, the nference mission is to synthesize the exponentially growing biomedical knowledge. nference uses state-of-the-art neural networks (shallow and deep learning models) for real-time, automated extraction of insights from the scientific, regulatory and commercial data sets. The platform enables a diverse set of applications ranging from R&D to commercial strategy and operations in the life sciences ecosystem. nference is making biomedical knowledge computable, and building its AI platform to serve as the connective fabric for various silos of information that exist in unstructured and structured form across health care enterprises. nference has also established a Joint Venture (Qrativ) with the Mayo Clinic for AI-driven drug purposing in rare diseases. nference is backed by Matrix Partners, Matrix Capital Management, and Mayo Clinic Ventures.
